BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36013249)

  • 1. First Two-Year Observational Exploratory Real Life Clinical Phenotyping, and Societal Impact Study of Parkinson's Disease in Emiratis and Expatriate Population of United Arab Emirates 2019-2021: The EmPark Study.
    Metta V; Ibrahim H; Loney T; Benamer HTS; Alhawai A; Almuhairi D; Al Shamsi A; Mohan S; Rodriguez K; Mohan J; O'Sullivan M; Muralidharan N; Al Mazrooei S; Dar Mousa K; Chung-Faye G; Mrudula R; Falup-Pecurariu C; Rodriguez Bilazquez C; Matar M; Borgohain R; Chaudhuri KR
    J Pers Med; 2022 Aug; 12(8):. PubMed ID: 36013249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
    Dafsari HS; Martinez-Martin P; Rizos A; Trost M; Dos Santos Ghilardi MG; Reddy P; Sauerbier A; Petry-Schmelzer JN; Kramberger M; Borgemeester RWK; Barbe MT; Ashkan K; Silverdale M; Evans J; Odin P; Fonoff ET; Fink GR; Henriksen T; Ebersbach G; Pirtošek Z; Visser-Vandewalle V; Antonini A; Timmermann L; Ray Chaudhuri K;
    Mov Disord; 2019 Mar; 34(3):353-365. PubMed ID: 30719763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease.
    Martinez-Martin P; Reddy P; Katzenschlager R; Antonini A; Todorova A; Odin P; Henriksen T; Martin A; Calandrella D; Rizos A; Bryndum N; Glad A; Dafsari HS; Timmermann L; Ebersbach G; Kramberger MG; Samuel M; Wenzel K; Tomantschger V; Storch A; Reichmann H; Pirtosek Z; Trost M; Svenningsson P; Palhagen S; Volkmann J; Chaudhuri KR
    Mov Disord; 2015 Apr; 30(4):510-6. PubMed ID: 25382161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
    Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms.
    Duncan GW; Khoo TK; Yarnall AJ; O'Brien JT; Coleman SY; Brooks DJ; Barker RA; Burn DJ
    Mov Disord; 2014 Feb; 29(2):195-202. PubMed ID: 24123307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Academy of Neurology/Movement Disorder Society-European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies.
    Deuschl G; Antonini A; Costa J; Śmiłowska K; Berg D; Corvol JC; Fabbrini G; Ferreira J; Foltynie T; Mir P; Schrag A; Seppi K; Taba P; Ruzicka E; Selikhova M; Henschke N; Villanueva G; Moro E
    Mov Disord; 2022 Jul; 37(7):1360-1374. PubMed ID: 35791767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profile of Nonmotor Symptoms and the Association with the Quality of Life of Parkinson's Disease Patients in Nigeria.
    Arabambi B; Oshinaike O; Ogun SA
    Niger Med J; 2019; 60(5):273-278. PubMed ID: 31844358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Self-Assessed State of Health and Vitamin D Knowledge in Emirati and International Female Students in United Arab Emirates (UAE).
    Abboud M; Rizk R; Papandreou D; Hijazi R; Al Emadi NE; Waszak PM
    Front Psychol; 2020; 11():1236. PubMed ID: 32595567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson's disease.
    Dafsari HS; Dos Santos Ghilardi MG; Visser-Vandewalle V; Rizos A; Ashkan K; Silverdale M; Evans J; Martinez RCR; Cury RG; Jost ST; Barbe MT; Fink GR; Antonini A; Ray-Chaudhuri K; Martinez-Martin P; Fonoff ET; Timmermann L;
    Brain Stimul; 2020; 13(6):1697-1705. PubMed ID: 33038595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Non-Motor Symptoms on Quality of Life in Patients with Early-Onset Parkinson's Disease.
    Patwardhan A; Kamble N; Bhattacharya A; Holla V; Yadav R; Pal PK
    Can J Neurol Sci; 2024 Jan; ():1-10. PubMed ID: 38178714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences of Living With the Nonmotor Symptoms of Parkinson's Disease: A Photovoice Study.
    Smith LJ; Callis J; Bridger-Smart S; Guilfoyle O
    Health Expect; 2024 Jun; 27(3):e14124. PubMed ID: 38924637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-motor symptoms and quality of life in tremor dominant vs postural instability gait disorder Parkinson's disease patients.
    Wu Y; Guo XY; Wei QQ; Ou RW; Song W; Cao B; Zhao B; Shang HF
    Acta Neurol Scand; 2016 May; 133(5):330-7. PubMed ID: 26195131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of Device-Aided Therapies in Parkinson's Disease: A Structured Review.
    Smilowska K; van Wamelen DJ; Pietrzykowski T; Calvano A; Rodriguez-Blazquez C; Martinez-Martin P; Odin P; Chaudhuri KR
    J Parkinsons Dis; 2021; 11(2):475-489. PubMed ID: 33386813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of Non-Motor symptoms on Health-Related quality of life in patients with young onset Parkinson's Disease: A single center Vietnamese Cross-Sectional study.
    Tran TN; Ha UNL; Nguyen TM; Nguyen TD; Vo KNC; Dang TH; Trinh PMP; Truong D
    Clin Park Relat Disord; 2021; 5():100118. PubMed ID: 34927047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of genetic disorders and gene variants in the United Arab Emirates national population: insights from the CTGA database.
    Bizzari S; Nair P; Hana S; Deepthi A; Al-Ali MT; Al-Gazali L; El-Hayek S
    Front Genet; 2023; 14():1177204. PubMed ID: 37214420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical phenotype of drug-naïve Parkinson's disease based on nonmotor symptoms.
    Lee HM; Lee SS; Kim M; Kang SH; Seo WK; Kim JH; Koh SB
    Arch Gerontol Geriatr; 2015; 61(3):517-22. PubMed ID: 26183203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The First United Arab Emirates National Representative Birth Cohort Study: Study Protocol.
    Mutare S; Feehan J; Cheikh Ismail L; Ali HI; Stojanovska L; Shehab A; Khair H; Ali R; Hwalla N; Kharroubi S; Hills AP; Fernandes M; Al Dhaheri AS
    Front Pediatr; 2022; 10():857034. PubMed ID: 35463875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delineating nonmotor symptoms in early Parkinson's disease and first-degree relatives.
    Baig F; Lawton M; Rolinski M; Ruffmann C; Nithi K; Evetts SG; Fernandes HR; Ben-Shlomo Y; Hu MT
    Mov Disord; 2015 Nov; 30(13):1759-66. PubMed ID: 26179331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Novel Mutations of Lysosomal Storage Disorders in United Arab Emirates : LSD in UAE.
    Al-Jasmi FA; Tawfig N; Berniah A; Ali BR; Taleb M; Hertecant JL; Bastaki F; Souid AK
    JIMD Rep; 2013; 10():1-9. PubMed ID: 23430803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off Time Independently Affects Quality of Life in Advanced Parkinson's Disease (APD) Patients but Not in Non-APD Patients: Results from the Self-Reported Japanese Quality-of-Life Survey of Parkinson's Disease (JAQPAD) Study.
    Hayashi Y; Nakagawa R; Ishido M; Yoshinaga Y; Watanabe J; Kurihara K; Nagaki K; Ogura H; Mishima T; Fujioka S; Tsuboi Y
    Parkinsons Dis; 2021; 2021():9917539. PubMed ID: 34676064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.